☆ 4.7 Review

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Cardiac & Cardiovascular Systems

Severe Bleeding Risk of Direct Oral Anticoagulants Versus Vitamin K Antagonists for Stroke Prevention and Treatment in Patients with Atrial Fibrillation: A Systematic Review and Network Meta-Analysis

Wenlin Xu et al.

Summary: This study aimed to evaluate the safety of direct oral anticoagulants (DOACs) for stroke prevention and treatment in patients with atrial fibrillation (AF). The study found that the safety rankings of DOACs varied for different types of bleeding events, emphasizing the need for further research to confirm these findings.

CARDIOVASCULAR DRUGS AND THERAPY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract Bleeding

So-Ryoung Lee et al.

Summary: The study found that PPI co-therapy was significantly associated with a reduced risk of major GIB in Asian patients with atrial fibrillation who were treated with oral anticoagulants (OACs) and had a prior history of upper GIB, particularly in patients treated with rivaroxaban and warfarin.

CARDIOVASCULAR DRUGS AND THERAPY (2022)

添加到收藏夹

Article Hematology

Drug-drug interactions: Implications for anticoagulation, with focus in patients with cancer

Tzu-Fei Wang

Summary: This paper reviews the existing evidence and guidelines on drug-drug interactions (DDIs) with anticoagulants, with a focus on the cancer population. It emphasizes the importance of anticoagulant therapy for cancer patients and highlights the potential impact of drug interactions on treatment efficacy and safety.

THROMBOSIS RESEARCH (2022)

添加到收藏夹

Article Multidisciplinary Sciences

Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy

Ho-Jun Jang et al.

Summary: This study aimed to find an appropriate anticoagulation cessation strategy in cases of gastrointestinal bleeding during oral anticoagulation therapy. The results showed that no single risk factor or drug cessation strategy was attributed to adverse clinical events. Therefore, future treatment should be individualized and controlled based on personalized risk assessment.

PLOS ONE (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gp

Tingting Zhao et al.

Summary: Cancer patients are at high risk of thrombotic diseases, but anticoagulant therapy increases bleeding risks. This study explores the combination safety of rivaroxaban with tyrosine kinase inhibitors (TKIs) and finds significant drug-drug interactions in different combinations. Imatinib increases bleeding risks while sunitinib reduces therapeutic efficacy. Therefore, caution should be exercised in the coadministration of rivaroxaban and TKIs to avoid harmful interactions.

FRONTIERS IN PHARMACOLOGY (2022)

添加到收藏夹

Review Environmental Sciences

The Risk of Gastrointestinal Bleeding between Non-Vitamin K Antagonist Oral Anticoagulants and Vitamin K Antagonists in the Asian Atrial Fibrillation Patients: A Meta-Analysis

Kuang-Tsu Yang et al.

Summary: The study compared the risk of gastrointestinal bleeding in Asian atrial fibrillation patients using non-vitamin K antagonist oral anticoagulants (NOACs) versus vitamin K antagonists (VKAs). Results showed that NOACs significantly reduced the risk of gastrointestinal bleeding compared to VKAs, with differences in risk among different NOACs. Further studies are needed to determine the most suitable NOAC for Asian AF patients and the optimal dosage regimen for each NOAC.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Comprehensive Exploration of Medications That Affect the Bleeding Risk of Oral Anticoagulant Users

Yohei Kawano et al.

Summary: The study found that certain antihypertensive drugs like amlodipine and bisoprolol may decrease the bleeding risk of oral anticoagulants, while other drugs such as telmisartan can increase the risk. It is important to consider pharmacokinetic-based drug interactions of direct oral anticoagulants to ensure safety.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter

Yang Mai et al.

Summary: This study investigated the expression of P-glycoprotein (P-gp) in the intestine of humans and Wistar rats using RT-PCR, Western blot, and LC-MS/MS techniques, revealing similar trends in gender differences and expression levels along the intestinal tract in both species. Strong positive linear correlation was observed between Western blot and LC-MS/MS data in the human small intestine. Conflicting results were shown in rat small intestinal and colonic P-gp expression between the techniques. The use of LC-MS/MS for quantification provided higher confidence in P-gp expression levels without the need for an internal reference protein.

MOLECULAR PHARMACEUTICS (2021)

添加到收藏夹

Review Hematology

Anticoagulant-associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants

Yan Xu et al.

Summary: Gastrointestinal bleeding is the most common site of major bleeding associated with oral anticoagulant, with patients facing up to 10% short-term all-cause mortality. Resumption of oral anticoagulant poses lower risks of thromboembolism and death but higher risks of recurrent bleeding. Treatment decisions should be individualized and take into consideration patient values and preferences based on the best available evidence.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)

添加到收藏夹

Article Cell Biology

Dabigatran Etexilate Induces Cytotoxicity in Rat Gastric Epithelial Cell Line via Mitochondrial Reactive Oxygen Species Production

Hiromi Kurokawa et al.

Summary: Dabigatran is a novel oral anticoagulant that inhibits thrombins, but its use may increase the risk of gastrointestinal bleeding. Research has shown that its main component, dabigatran etexilate, exhibits cytotoxicity that can be inhibited by ascorbic acid. These cytotoxic effects are likely mediated via mitROS production.

CELLS (2021)

添加到收藏夹

Article Medicine, General & Internal

Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal Bleeding

Gregory Y. H. Lip et al.

Summary: In this study of patients with NVAF and high risk of GI bleed, NOACs were associated with lower rates of stroke and/or SE, but NOACs had varying risks of MB compared with warfarin. These results may help inform treatment options in this patient population.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis

Zhi-Chun Gu et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

添加到收藏夹

Review Emergency Medicine

CURRENT STRATEGIES FOR THE MANAGEMENT OF BLEEDING ASSOCIATED WITH DIRECT ORAL ANTICOAGULANTS AND A REVIEW OF INVESTIGATIONAL REVERSAL AGENTS

Colin G. Kaide et al.

JOURNAL OF EMERGENCY MEDICINE (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding

Sarah Hanigan et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulants

Charles J. Ferro et al.

PHARMACOLOGY RESEARCH & PERSPECTIVES (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Drug-Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review

Marta Bellesini et al.

CLINICAL DRUG INVESTIGATION (2020)

添加到收藏夹

Review Hematology

Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review

Allen Li et al.

THROMBOSIS RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation

So-Ryoung Lee et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Re-evaluating Safety and Effectiveness of Dabigatran Versus Warfarin in a Nationwide Data Environment: A Prevalent New-User Design Study

Hui-Min Diana Lin et al.

DRUGS-REAL WORLD OUTCOMES (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition

Sophie Hodin et al.

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)

Paolo Gelosa et al.

PHARMACOLOGICAL RESEARCH (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Gastrointestinal Safety of Direct Oral Anticoagulants: A Large Population-Based Study

Neena S. Abraham et al.

GASTROENTEROLOGY (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)

Hakeam A. Hakeam et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation

Xiaoxi Yao et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial

Eri Toda Kato et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

Sameer Bansilal et al.

AMERICAN HEART JOURNAL (2015)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Alvaro Avezum et al.

CIRCULATION (2015)

添加到收藏夹

Review Pharmacology & Pharmacy

Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

Stefan Wolking et al.

CLINICAL PHARMACOKINETICS (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials

Lorenzo Loffredo et al.

DIGESTIVE AND LIVER DISEASE (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

Management of anticoagulation in patients with acute gastrointestinal bleeding

Franco Radaelli et al.

DIGESTIVE AND LIVER DISEASE (2015)

添加到收藏夹

Editorial Material Medicine, General & Internal

Do the direct anti-coagulants bleed the digestive tube?

Helene Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2015)

添加到收藏夹

Editorial Material Medicine, General & Internal

Do the direct anti-coagulants bleed the digestive tube?

Helene Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2015)

添加到收藏夹

Article Medicine, General & Internal

Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study

Hsien-Yen Chang et al.

BMJ-BRITISH MEDICAL JOURNAL (2015)

添加到收藏夹

Article Medicine, General & Internal

The newer direct oral anticoagulants: a practical guide

Jecko Thachil

CLINICAL MEDICINE (2014)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)

Paul A. Reilly et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

添加到收藏夹

Article Hematology

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

Thomas Vanassche et al.

THROMBOSIS AND HAEMOSTASIS (2014)

添加到收藏夹

Review Gastroenterology & Hepatology

New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis

I. Lisanne Holster et al.

GASTROENTEROLOGY (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Efficacy and Safety of Dabigatran Etexilate and Warfarin in Real-World Patients With Atrial Fibrillation A Prospective Nationwide Cohort Study

Torben Bjerregaard Larsen et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

添加到收藏夹

Article Medicine, General & Internal

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

添加到收藏夹

Article Hematology

Gastrointestinal bleeding with the new oral anticoagulants - defining the issues and the management strategies

Jay Desai et al.

THROMBOSIS AND HAEMOSTASIS (2013)

添加到收藏夹

Article Education, Scientific Disciplines

Pros and cons of new oral anticoagulants

Kenneth A. Bauer

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2013)

添加到收藏夹

Article Pharmacology & Pharmacy

Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats

Donglu Zhang et al.

DRUG METABOLISM AND DISPOSITION (2013)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation

Corey S. Miller et al.

AMERICAN JOURNAL OF CARDIOLOGY (2012)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial

John W. Eikelboom et al.

CIRCULATION (2011)

添加到收藏夹

Article Pharmacology & Pharmacy

In Vitro and In Vivo P-Glycoprotein Transport Characteristics of Rivaroxaban

Mark Jean Gnoth et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)

添加到收藏夹

Article Medicine, General & Internal

Dabigatran versus Warfarin in Patients with Atrial Fibrillation.

Stuart J. Connolly et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

添加到收藏夹

Article Multidisciplinary Sciences

Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding

Stephen G. Aller et al.

SCIENCE (2009)

添加到收藏夹

Article Pharmacology & Pharmacy

Regional levels of drug transporters along the human intestinal tract:: Co-expression of ABC and SLC transporters and comparison with Caco-2 cells

Gunilla Englund et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)

添加到收藏夹

Review Cell Biology

The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics

Y Sambuy et al.

CELL BIOLOGY AND TOXICOLOGY (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.